$2.11 Billion is the total value of NEA Management Company, LLC's 47 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPT | New | SPROUT SOCIAL INC | $145,190,000 | – | 9,046,080 | +100.0% | 6.87% | – |
| OYST | New | OYSTER POINT PHARMA INC | $144,814,000 | – | 5,925,287 | +100.0% | 6.85% | – |
| ARDX | Buy | ARDELYX INC | $121,013,000 | +67.9% | 16,135,047 | +5.2% | 5.72% | -4.1% |
| GRTX | New | GALERA THERAPEUTICS INC | $57,417,000 | – | 4,362,986 | +100.0% | 2.72% | – |
| MEIP | Buy | MEI PHARMA INC | $21,162,000 | +120.2% | 8,533,072 | +49.2% | 1.00% | +25.8% |
| AFMD | Buy | AFFIMED NV | $16,787,000 | +11.1% | 6,126,488 | +19.2% | 0.79% | -36.5% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $13,007,000 | +139.5% | 992,107 | +64.6% | 0.62% | +36.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.